Overview
Mohammad Abdul-Hay is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Abdul-Hay is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 4 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic B-Cell Leukemia (CBCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
560 1st Ave, New York, NY 10016
111 Broadway, New York, NY 10006
240 E 38th St, New York, NY 10016
160 E 34th St, New York, NY 10016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Weill Medical College Of Cornell
John Allan is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Allan has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Splenectomy.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Abdul-Hay isDistinguished. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Abdul-Hay isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Abdul-Hay isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaDr. Abdul-Hay isAdvanced. Learn about Adult T-Cell Leukemia.
- Bone Marrow TransplantDr. Abdul-Hay isAdvanced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaDr. Abdul-Hay isAdvanced. Learn about Burkitt Lymphoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Abdul-Hay isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Abdul-Hay isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Abdul-Hay isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Abdul-Hay isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Abdul-Hay isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Abdul-Hay isExperienced. Learn about Anemia.